1. Home
  2. VTRS vs EXPD Comparison

VTRS vs EXPD Comparison

Compare VTRS & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$16.55

Market Cap

17.7B

Sector

Health Care

ML Signal

HOLD

Logo Expeditors International of Washington Inc.

EXPD

Expeditors International of Washington Inc.

HOLD

Current Price

$156.56

Market Cap

19.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTRS
EXPD
Founded
1961
1979
Country
United States
United States
Employees
30000
N/A
Industry
Medicinal Chemicals and Botanical Products
Oil Refining/Marketing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
17.7B
19.6B
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
VTRS
EXPD
Price
$16.55
$156.56
Analyst Decision
Buy
Hold
Analyst Count
4
11
Target Price
$13.50
$133.00
AVG Volume (30 Days)
12.4M
990.6K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
3.21%
1.03%
EPS Growth
N/A
4.02
EPS
0.15
1.71
Revenue
$14,299,900,000.00
$6,920,948,000.00
Revenue This Year
$4.41
$2.71
Revenue Next Year
$1.96
$3.74
P/E Ratio
$110.03
$91.23
Revenue Growth
N/A
13.49
52 Week Low
$8.19
$109.90
52 Week High
$17.53
$167.19

Technical Indicators

Market Signals
Indicator
VTRS
EXPD
Relative Strength Index (RSI) 63.17 60.34
Support Level $9.82 $138.55
Resistance Level N/A $165.83
Average True Range (ATR) 0.57 4.37
MACD 0.06 0.58
Stochastic Oscillator 64.84 96.51

Price Performance

Historical Comparison
VTRS
EXPD

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About EXPD Expeditors International of Washington Inc.

Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 35% of consolidated gross revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.

Share on Social Networks: